Skip to main content
Equibles
ZLAB logo

ZLAB · Zai Lab Ltd

Track ZLAB — free Ask ALVIS about ZLAB
$21.67 +3.30 (+17.96%) Earnings today
Customer concentration — top customer 25% of receivables

One customer — 25% of receivables (As of March 31, 2026)

“As of March 31, 2026, our largest customer accounted for approximately 25% of our total accounts receivable collectively.”
View the 10-Q filed May 7, 2026
Market Cap
$26.89B
Shares
1.46B

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$18.37 Open$18.51 Day$18.22–18.54 52W$15.96–39.64 Avg vol 30d738K Short int6.4M · 0.4% float · 7.5d Short vol68% Last earningsAug 6, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 6

Up next

Earnings call today
Aug 6, 2026 Today
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 6, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Sell Momentum Weak Sentiment Neutral Fundamentals Strong Quant / Vol Very High
      Market backdrop VIX 15.8 · calm Equity put/call 0.46
      Technical
      price trend
      Sell
      50 / 200-day cross No cross
      Price vs 200-day avg −7%
      below
      Price vs 50-day avg −1%
      below
      RSI (14) 42
      neutral
      MACD trend Negative
      52-week position 10%
      near low
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Weak
      1-month return −7%
      trailing
      6-month return −3%
      trailing
      YTD return +4%
      this year
      Relative strength −15%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $19 › 200d $20 — 200d above 50d
      Institutional flow Accumulating
      26 of 99 funds reported for Jun 30 · net +212.6K sh shares · +2 new
      Insider flow Distributing
      Net -$4.7M over 90 days · 100% sells
      Short interest Falling
      0.43% of float · ▼ -22.1% MoM · 7.5 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr low
      99 holders — near 3-yr low, contrarian setup
      Squeeze score 38
      low risk · 0–100
      Fundamentals
      Strong
      Revenue growth +15%
      Y/Y
      Gross margin 0%
      EPS growth +38%
      Y/Y
      Free cash flow $-158.9M
      Balance sheet $679.6M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 50%
      annualized · 1-yr
      Max drawdown −59%
      past year
      ATR 3.8%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the Earnings Call filed Jun 30, 2025
      Full year revenue · full year Maintained $560M – $590M
      prior FY $460.16M midpoint +25.0% Y/Y
      Guided vs delivered · last 1 settled
      Full year revenue full year
      guided $560M – $590M
      $460.16M Miss −20.0%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Sell
      3 · 4 · 0
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −7% Bearish
      Price vs 50-day avg
      −1% Neutral
      RSI (14)
      42 Neutral
      MACD trend
      Negative Bearish
      52-week position
      10% Bearish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $19 › 200d $20 — 200d above 50d
      Institutional flow Accumulating
      26 of 99 funds reported for Jun 30 · net +212.6K sh shares · +2 new
      Insider flow Distributing
      Net -$4.7M over 90 days · 100% sells
      Short interest Falling
      0.43% of float · ▼ -22.1% MoM · 7.5 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr low
      99 holders — near 3-yr low, contrarian setup
      Price context
      position in its 52-week range
      52-wk low $16 Now $18 · 10% 52-wk high $40
      vs 200-day avg -7% vs 50-day avg -1%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from its earnings releases, calls, and filings
      Metric Latest Period YoY
      Adjusted loss from operations non-GAAP $51.9M first quarter of 2026 —
      GAAP → non-GAAP reconciliation
      GAAP Loss from operations -69,385K
      +3,944K Depreciation and amortization expenses
      +13,524K Share-based compensation
      = Adjusted loss from operations -51,917K
      Product revenue, net non-GAAP 15% Full-year 2025 —
      Product revenue, net (At CER) non-GAAP 16% Full-year 2025 —

      Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

      Versus peers

      Biotechnology — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      ZLAB
      Zai Lab Ltd
      this stock
      		$26.89B +4.1% +24.0% — 0.4%
      ONC
      BeOne Medicines Ltd.
      		 $484.13B +7.8% +22179.2% 744.4 0.1%
      VRTX
      Vertex Pharmaceuticals Inc / Ma
      		 $122.89B +6.9% +46.2% 28.2 2.0%
      REGN
      Regeneron Pharmaceuticals, Inc.
      		 $79.13B -0.2% +20.8% 19.0 3.4%
      ARGX
      Argenx SE
      		 $54.30B +3.2% — — 2.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      93
      % held
      2.0%
      Reported
      26 of 99
      Top holder
      RTW INVESTMENTS, LP
      Held Float
      View
      Held by Funds
      Fund positions
      42
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      6.4M
      Days to cover
      7.5d
      Change
      -1.8M sh
      View
      Short Volume
      Short vol %
      68%
      As of
      Aug 5, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      1.9K
      Value
      $38.0K
      As of
      Jul 13, 2026
      View
      Off-Exchange
      Off-exchange %
      33.8%
      Week of
      Jun 29, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$4.7M
      Buyers / Sellers
      0 / 3
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $460.2M
      Net income (FY)
      $-175.5M
      EPS diluted
      $-0.16
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 6, 2026
      This year
      9
      View
      Proposed Sales
      Value
      $130.2K
      Shares
      7.0K
      Filed
      Jun 30, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 6, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      ZLAB +0.3% -7.0% -3.5% +0.6% +4.1%
      SPY +5.5% +3.3% +11.3% +3.1% +12.9%
      vs SPY -5.2% -10.3% -14.7% -2.5% -8.8%
      Key facts CIK 1704292 CUSIP 98887Q104 13F (30d) 31 filings 19 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)